STADA and Calliditas announce the filing for full marketing authorization of Kinpeygo® in the EU ...Middle East

News by : (PR Newswire) -
Request submitted by STADA to EMA to convert conditional marketing authorization to standard marketing authorization for Kinpeygo treatment for primary IgA nephropathy Submission to the CHMP for full approval is based on the full two-year data set from the Phase 3 NefIgArd clinical trial,...

Hence then, the article about stada and calliditas announce the filing for full marketing authorization of kinpeygo in the eu was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( STADA and Calliditas announce the filing for full marketing authorization of Kinpeygo® in the EU )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار